Acadia Pharmaceuticals nomina Doug Williamson, MD, Executive Vice President, Head of Research and Development :
https://acadia.com/media/news-relea...e-president-head-of-research-and-development/
Here they talk about us:
https://www.biopharmadive.com/news/5-fda-approval-decisions-first-quarter-2023/639507/
Acadia Pharmaceuticals nomina Doug Williamson, MD, Executive...
-
- There are more pages in this discussion • 7,583 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.63 |
Change
0.410(2.03%) |
Mkt cap ! $2.652B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $21.10 | $20.39 | $5.572M | 268.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 323 | $20.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.64 | 1079 | 14 |
View Market Depth
| Last trade - 14.37pm 26/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |